🕵️ Metagenomi Therapeutics, Inc. ($MGX)
SEC insider & ownership activity, last 12 months · CIK 1785279 · every row links its SEC filing
Over the last 12 months insiders sold $44K against $23K of open-market buying. Reid Laurence bought $23K in discretionary trades (Sep). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $23K (2 lots) · 4 sellers, $44K (17 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Reid Laurence | 2 | $23K | 0 | – | Sep 9, 2026 |
| Irish Jian | 0 | – | 5 | $16K | Sep 8, 2026 |
| Wapnick Pamela | 0 | – | 5 | $14K | Sep 8, 2026 |
| Brian C. Thomas | 0 | – | 2 | $12K | Dec 5, 2025 |
| Wein Matthew | 0 | – | 5 | $3K | Sep 8, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Brian C. Thomas | 7.3% | 13G | Sep 10, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 11, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 11, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 29, 2025 | filing ↗ |
| Agreement terminated (1.02) | Sep 29, 2025 | filing ↗ |